Levocetirizine Dihydrochloride
- Product NDC
- 71335-0162
- 11-digit product format
- 713350162
- Labeler code
- 71335
- Product ID
- 71335-0162_2304ce98-92c7-4493-8da7-19ce43c56d99
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levocetirizine Dihydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203027
- Marketing category
- ANDA
- Marketing start
- 2015-02-13
- Marketing end
- 0000-00-00
- Substance
- LEVOCETIRIZINE DIHYDROCHLORIDE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71335-0162-1 | 71335016201 | 30 TABLET in 1 BOTTLE (71335-0162-1) | 30 tablet | 2017-10-25 | 0000-00-00 | No | No | Current |
| 71335-0162-2 | 71335016202 | 90 TABLET in 1 BOTTLE (71335-0162-2) | 90 tablet | 2017-10-25 | 0000-00-00 | No | No | Current |
| 71335-0162-3 | 71335016203 | 28 TABLET in 1 BOTTLE (71335-0162-3) | 28 tablet | 2017-10-25 | 0000-00-00 | No | No | Current |
| 71335-0162-4 | 71335016204 | 60 TABLET in 1 BOTTLE (71335-0162-4) | 60 tablet | 2017-10-25 | 0000-00-00 | No | No | Current |